Regeneron
is a New York-based biotechnology company that researches, develops, and commercializes novel therapeutics for the treatment of inflammatory and infectious diseases... Read moreRegeneron
is a New York-based biotechnology company that researches, develops, and commercializes novel therapeutics for the treatment of inflammatory and infectious diseases... Read more
News
Partnership
Dec 01, 2025
Contract Pharma
Regeneron, Tessera Therapeutics Partner to Develop & Commercialize TSRA-196
Regulatory
Oct 10, 2025
Pharmabiz
Regeneron gests US FDA approval for Libtayo as an adjuvant treatment of CSCC with a high risk of recurrence after surgery and radiation
Conference Presentation
Sep 04, 2025
Benzinga
Regeneron Announces Updated Presentation Time for Upcoming Investor Conference
Acquisition
May 19, 2025
Citybizlist
Regeneron acquired 23andMe, Inc for $256M
Regeneron Competitors
1
2
3
4
5
6
7
8
9
10